DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 126 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q3 2019. The put-call ratio across all filers is 1.42 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $3,806,000 | -10.0% | 112,011 | -3.0% | 0.00% | -25.0% |
| Q2 2021 | $4,227,000 | -21.2% | 115,459 | -3.5% | 0.00% | -20.0% |
| Q1 2021 | $5,365,000 | -0.4% | 119,641 | +26.7% | 0.01% | 0.0% |
| Q4 2020 | $5,388,000 | +26.9% | 94,416 | +14.1% | 0.01% | 0.0% |
| Q3 2020 | $4,245,000 | -19.9% | 82,752 | -6.7% | 0.01% | -16.7% |
| Q2 2020 | $5,297,000 | +55.6% | 88,701 | +7.3% | 0.01% | +20.0% |
| Q1 2020 | $3,405,000 | +1.9% | 82,689 | +54.0% | 0.01% | +66.7% |
| Q4 2019 | $3,343,000 | +526.0% | 53,711 | +237.0% | 0.00% | +200.0% |
| Q3 2019 | $534,000 | +42.8% | 15,940 | -3.9% | 0.00% | – |
| Q2 2019 | $374,000 | – | 16,591 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 4,104,140 | $93,041,000 | 43.52% |
| SV Health Investors, LLC | 1,716,303 | $38,909,000 | 20.55% |
| PURA VIDA INVESTMENTS, LLC | 68,154 | $1,545,000 | 0.65% |
| Redmile Group, LLC | 683,880 | $14,658,000 | 0.64% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 77,000 | $1,746,000 | 0.62% |
| SPHERA FUNDS MANAGEMENT LTD. | 224,154 | $5,008,000 | 0.59% |
| EMERALD ADVISERS, LLC | 482,626 | $10,941,000 | 0.42% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 416,342 | $9,438,000 | 0.38% |
| Orbimed Advisors | 1,176,070 | $26,662,000 | 0.34% |
| VIKING GLOBAL INVESTORS LP | 2,394,625 | $54,286,000 | 0.33% |